First patient dosed in Phase IIb imaging for Brain Mets

by admin April 28, 2025

April 28, 2025

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

0

Facebook Twitter Google +Pinterest

Heritage Mining Appoints Thomas Reid CPA, CA to...

Are We in a Recession? Predictions, Signs and...

FPX Nickel Announces Board and Management Changes

Lancaster Resources MT Results Show Strong Lithium Targets

Syntheia Signs Maiden Enterprise Deal with Van-Fort Ontario

Quimbaya Gold Closes Final Tranche of Private Placement...

Jordan Roy-Byrne: Gold Hyperbole is Real, Price Setup...

How to Invest in Molybdenum Stocks (Updated 2024)

Beyond Lithium Intersects 2.30% Li2O over 3.84m in...

BPH Energy Ltd Raises $2.25 Million to Accelerate...

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Latest

Japan’s farm minister resigns over rice gaffe, as stubbornly high prices threaten...
Three children and two adults killed in suicide attack on school bus in Pakistan
Exclusive: Intercepted radio chatter and drone footage appear to capture Russian orders to kill surrendering Ukrainian troops
Putin makes first visit to Kursk since Russia claimed to have recaptured the region
Speaker Johnson reaches tentative deal with blue state Republicans to boost cap on ‘SALT’ deduction

Categories

Business (1,653)
Investing (4,882)
Politics (7,720)
Uncategorized (2)
World (6,253)

About us
Contacts
Privacy Policy
Terms & Conditions
Email Whitelisting

Disclaimer: toppricemarket.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Back To Top

First patient dosed in Phase IIb imaging for Brain Mets

Waltz doubles down on Hegseth praise amid ongoing Pentagon controversy

RHI: Acqn of royalty over Sandstone Gold Project tenements

You may also like